Artelo Biosciences (ARTL) Stock Soars After Positive Preclinical Results
Monday saw a spectacular increase in the share price of Artelo Biosciences, Inc. (NASDAQ: ARTL), which shot up 95.72% to close at $13.27. The dramatic increase followed positive findings from a first-in-human clinical trial assessing ART26.12, a potential treatment candidate with a distinct mode of action that targets chronic pain. Positive Findings Artelo’s Phase 1 […]